According to Fortune Business Insights, the global Reading Glasses Market size is projected to reach USD 53.23 Billion in 2026, at CAGR of 5.4% during.
Global Dermal Fillers Market Highlights:
The Dermal Fillers Market report offers an in-depth analysis of the Dermal Fillers industry and the demand drivers by highlighting information on several aspects of the market. Prudent Markets addresses all these aspects and provides the latest scoop and detailed eye-opening study on all major & emerging business segments. In addition to this, the report sheds light on the industry developments by key players, which are contributing to the expansion of this industry. The development scope, feasibility study, Dermal Fillers market concentration, and maturity analysis is elaborated in this report.
Information given in the research report pertains to different technological advancements introduced in recent years, which allows for a meticulous analysis of the industry and offers a more comprehensive understanding to the readers.
North America Osteoporosis Treatment Market to Reach USD 8.29 Billion with 6.6% CAGR by 2027; Increasing Prevalence of Osteoporosis to Stoke Demand: Fortune Business Insights™ Top Players Covered in North America Osteoporosis Treatment Market are AbbVie Inc., Eli Lilly and Company, Amgen Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Sanofi, Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Alcon and Others.
February 22, 2021 05:10 ET | Source: Fortune Business Insights Fortune Business Insights
Pune, India, Feb. 22, 2021 (GLOBE NEWSWIRE) The
North America osteoporosis treatment market size is expected to gain momentum by reaching USD 8.29 billion by 2027 while exhibiting a CAGR of 6.6% between 2020 and 2027. This is attributable to the increasing prevalence of osteoporosis and the growing number of government approvals for the therapeutic drugs that are propelling the demand in the North America osteoporosis treatment options.
(MENAFN - GlobeNewsWire - Nasdaq) Pune, India, Feb. 18, 2021 (GLOBE NEWSWIRE) Recent technological advancements in digital healthcare devices and equipment is expected to drive the global nanopore technologies market . The emergence of digitalization has transformed the nanopore technologies. In the process of nanopore technology sequencing, current passes nano-sized pores and are later used for protein sequencing. This sequencing information is collected in the form of electronic data. Owing to the adoption of the internet of things (IoT), this technology can be effectively employed for the sequencing of human genome. This technology has a higher preference than other technologies owing to its cost-effectiveness and quicker results. Moreover, researchers are planning to develop molecule detectors and sequencers by adopting this technology.